TSPAN31 (TSN31_HUMAN) as a Potential Drug Target and Biomarker

Target Name: TSPAN31

NCBI ID: G6302

TSPAN31

TSPAN31 (TSN31_HUMAN) as a Potential Drug Target and Biomarker

Abstract: TSPAN31 (T-Spanin-31) is a highly conserved protein that is expressed in various tissues of the human body. It is known to play a crucial role in various cellular processes, including cell signaling, DNA replication, and cell adhesion. The human version of TSPAN31, TSN31HUMAN, has been identified as a potential drug target and biomarker. This article will discuss the current understanding of TSPAN31HUMAN, its potential drug targeting potential, and its role as a biomarker in various diseases.

Introduction:

TSPAN31 (T-Spanin-31) is a protein that is highly conserved across various species, including humans. It is known to play a crucial role in various cellular processes, including cell signaling, DNA replication, and cell adhesion. TSPAN31 is expressed in various tissues of the human body, including the brain, heart, liver, and kidney. It is also involved in various signaling pathways, including the TGF-β pathway, which plays a crucial role in cell signaling and development.

Potential Drug Target:

TSPAN31HUMAN has been identified as a potential drug target due to its various functions in cellular signaling. It is known to interact with various signaling pathways, including the TGF-β pathway. This pathway is involved in cell signaling and development, and is a key target for many diseases, including cancer. TSPAN31HUMAN has been shown to play a role in regulating TGF-β signaling, which is crucial for cell growth, differentiation, and survival.

TSPAN31HUMAN has also been shown to interact with other signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in cell signaling and metabolism, and is also a key target for many diseases, including diabetes. TSPAN31HUMAN has been shown to play a role in regulating PI3K/Akt signaling pathway, which is crucial for cell signaling and metabolism.

Biomarker Potential:

TSPAN31HUMAN has also been identified as a potential biomarker for various diseases. As mentioned earlier, TSPAN31 is involved in various signaling pathways, including the TGF-β pathway. This pathway is involved in cell signaling and development, and is a key target for many diseases, including cancer. TSPAN31HUMAN has been shown to play a role in regulating TGF-β signaling, which is crucial for cell growth, differentiation, and survival.

TSPAN31HUMAN has also been shown to interact with other signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in cell signaling and metabolism, and is also a key target for many diseases, including diabetes. TSPAN31HUMAN has been shown to play a role in regulating PI3K/Akt signaling pathway, which is crucial for cell signaling and metabolism.

Conclusion:

TSPAN31HUMAN is a highly conserved protein that is expressed in various tissues of the human body. It is known to play a crucial role in various cellular processes, including cell signaling, DNA replication, and cell adhesion. The human version of TSPAN31, TSN31HUMAN, has been identified as a potential drug target and biomarker due to its various functions in cellular signaling. Further research is needed to fully understand the potential of TSPAN31HUMAN as a drug target and biomarker.

Protein Name: Tetraspanin 31

The "TSPAN31 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSPAN31 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets